Tennant Company (NYSE:TNC) had an increase of 3.26% in short interest. TNC’s SI was 932,600 shares in May as released by FINRA. Its up 3.26% from 903,200 shares previously. With 109,800 avg volume, 9 days are for Tennant Company (NYSE:TNC)’s short sellers to cover TNC’s short positions. The SI to Tennant Company’s float is 6.21%. The stock increased 2.16% or $1.6 during the last trading session, reaching $75.7. About 28,005 shares traded. Tennant Company (NYSE:TNC) has declined 4.44% since May 16, 2017 and is downtrending. It has underperformed by 15.99% the S&P500.
The stock of Cocrystal Pharma, Inc. (NASDAQ:COCP) is a huge mover today! The stock decreased 8.76% or $0.19 during the last trading session, reaching $1.98. About 97,788 shares traded or 100.71% up from the average. Cocrystal Pharma, Inc. (NASDAQ:COCP) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.The move comes after 7 months negative chart setup for the $56.65 million company. It was reported on May, 16 by Barchart.com. We have $1.90 PT which if reached, will make NASDAQ:COCP worth $2.27 million less.
More news for Tennant Company (NYSE:TNC) were recently published by: Finance.Yahoo.com, which released: “Is Tennant Company (NYSE:TNC) A Financially Sound Company?” on April 24, 2018. Seekingalpha.com‘s article titled: “Tennant Company 2018 Q1 – Results – Earnings Call Slides” and published on April 24, 2018 is yet another important article.
Tennant Company designs, manufactures, and markets cleaning solutions. The company has market cap of $1.36 billion. It offers floor maintenance and outdoor cleaning equipment, detergent -free and other sustainable cleaning technologies, aftermarket parts and consumables, and specialty surface coatings. It currently has negative earnings. The firm also provides equipment maintenance and repair services; and business solutions, such as financing, rental, and leasing programs, as well as machine-to-machine asset management solutions.
Since January 11, 2018, it had 0 insider purchases, and 9 selling transactions for $9.37 million activity. Shares for $48,472 were sold by Zay Richard H.. $487,998 worth of Tennant Company (NYSE:TNC) shares were sold by PAULSON THOMAS. The insider KILLINGSTAD CHRIS sold 13,281 shares worth $907,825. Huml David W. sold $30,293 worth of stock or 415 shares.
Among 3 analysts covering Tennant Co (NYSE:TNC), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Tennant Co had 5 analyst reports since October 28, 2015 according to SRatingsIntel. The stock of Tennant Company (NYSE:TNC) earned “Hold” rating by Jefferies on Thursday, June 15. The rating was upgraded by Dougherty on Monday, February 26 to “Buy”. The firm has “Buy” rating by Dougherty & Company given on Wednesday, October 28.
Investors sentiment decreased to 1.25 in 2017 Q4. Its down 0.06, from 1.31 in 2017Q3. It is negative, as 14 investors sold Tennant Company shares while 41 reduced holdings. 23 funds opened positions while 46 raised stakes. 15.88 million shares or 2.59% less from 16.30 million shares in 2017Q3 were reported. Ls Invest Advisors Limited Liability holds 0% of its portfolio in Tennant Company (NYSE:TNC) for 515 shares. Van Eck Associates stated it has 0% in Tennant Company (NYSE:TNC). Aperio Grp Inc Ltd Liability invested in 0% or 8,761 shares. Bnp Paribas Arbitrage owns 0% invested in Tennant Company (NYSE:TNC) for 7,350 shares. Schwab Charles Mgmt Incorporated has invested 0.01% in Tennant Company (NYSE:TNC). Credit Suisse Ag stated it has 0% of its portfolio in Tennant Company (NYSE:TNC). Sfe Inv Counsel accumulated 29,612 shares. State Street Corporation owns 443,703 shares. Dorsey Whitney Trust Com Limited Liability Com stated it has 23,486 shares or 0.31% of all its holdings. Sns Fincl Gp Lc holds 0.06% or 3,175 shares. Vanguard holds 1.82 million shares. Howe Rusling invested in 0% or 44 shares. 14,084 were accumulated by State Of Tennessee Treasury Department. Us Fincl Bank De holds 239,990 shares. Pub Employees Retirement Sys Of Ohio holds 0% of its portfolio in Tennant Company (NYSE:TNC) for 1,460 shares.
More notable recent Cocrystal Pharma, Inc. (NASDAQ:COCP) news were published by: Globenewswire.com which released: “COCRYSTAL PHARMA, INC., PRICES $8000000 COMMON STOCK OFFERING” on May 01, 2018, also Nasdaq.com with their article: “Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update” published on May 11, 2018, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings” on May 02, 2018. More interesting news about Cocrystal Pharma, Inc. (NASDAQ:COCP) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Catabasis Soars On Trial Results, Eloxx Listing, Biomarin Earnings” published on April 26, 2018 as well as Benzinga.com‘s news article titled: “35 Stocks Moving In Friday’s Mid-Day Session” with publication date: April 27, 2018.
Cocrystal Pharma, Inc. focuses on developing novel medicines for use in the treatment of human viral diseases. The company has market cap of $56.65 million. It has developed proprietary structure drug design and antiviral nucleoside chemistry to create antiviral drug candidates. It currently has negative earnings. The firm is developing antiviral drug candidates designed to transform the treatment and/or prophylaxis of hepatitis C virus, influenza virus, and norovirus.